Taken together, our data suggests that ASS1 and ASL act as potential metabolic tumor suppressors in ccRCC, and their loss conserves cellular aspartate pools and regulates nitric oxide generation to give ccRCC cells a proliferative edge. The gene discussed is ASS1; the disease is nonpapillary renal cell carcinoma.